BMJ Editor "Science is Being Suppressed for Political and Financial Gain"
The Executive Editor of the BMJ, Kamran Abbasi, has written a blistering editorial taking aim at the “state corruption” that Covid has unleashed.
For an editorial like this to appear in a leading scientific journal is unprecedented. In the article Abbasi states:
Politicians and governments are suppressing science. They do so in the public interest, they say, to accelerate availability of diagnostics and treatments. They do so to support innovation, to bring products to market at unprecedented speed. Both of these reasons are partly plausible; the greatest deceptions are founded in a grain of truth. But the underlying behaviour is troubling.
Science is being suppressed for political and financial gain. COVID-19 has unleashed state corruption on a grand scale, and it is harmful to public health. Politicians and industry are responsible for this opportunistic embezzlement. So too are scientists and health experts. The pandemic has revealed how the medical-political complex can be manipulated in an emergency – a time when it is even more important to safeguard science.
The UK’s pandemic response provides at least four examples of suppression of science or scientists. First, the membership, research, and deliberations of the Scientific Advisory Group for Emergencies (SAGE) were initially secret until a press leak forced transparency. The leak revealed inappropriate involvement of government advisers in SAGE, while exposing under-representation from public health, clinical care, women, and ethnic minorities. Indeed, the Government was also recently ordered to release a 2016 report on deficiencies in pandemic preparedness, Operation Cygnus, following a verdict from the Information Commissioner’s Office.
Next, a Public Health England report on COVID-19 and inequalities. The report’s publication was delayed by England’s Department of Health; a section on ethnic minorities was initially withheld and then, following a public outcry, was published as part of a follow-up report. Authors from Public Health England were instructed not to talk to the media. Third, on October 15th, the editor of the Lancet complained that an author of a research paper, a UK Government scientist, was blocked by the Government from speaking to media because of a “difficult political landscape”.
Now, a new example concerns the controversy over point-of-care antibody testing for COVID-19. The Prime Minister’s Operation Moonshot depends on immediate and wide availability of accurate rapid diagnostic tests. It also depends on the questionable logic of mass screening – currently being trialled in Liverpool with a suboptimal PCR test.
The incident relates to research published this week by the BMJ, which finds that the Government procured an antibody test that in real world tests falls well short of performance claims made by its manufacturers. Researchers from Public Health England and collaborating institutions sensibly pushed to publish their study findings before the government committed to buying a million of these tests but were blocked by the health department and the prime minister’s office. Why was it important to procure this product without due scrutiny? Prior publication of research on a preprint server or a government website is compatible with The BMJ’s publication policy. As if to prove a point, Public Health England then unsuccessfully attempted to block The BMJ’s press release about the research paper.
The BMJ's executive editor then goes on to support Mike Yeadon’s hypothesis – that we’re witnessing a “convergence of opportunism” during this crisis.
The UK’s pandemic response relies too heavily on scientists and other Government appointees with worrying competing interests, including shareholdings in companies that manufacture COVID-19 diagnostic tests, treatments, and vaccines. Government appointees are able to ignore or cherry pick science – another form of misuse – and indulge in anti-competitive practices that favour their own products and those of friends and associates.
How might science be safeguarded in these exceptional times? The first step is full disclosure of competing interests from Government, politicians, scientific advisers, and appointees, such as the heads of Test and Trace, diagnostic test procurement, and vaccine delivery. The next step is full transparency about decision making systems, processes, and knowing who is accountable for what.
Once transparency and accountability are established as norms, individuals employed by government should ideally only work in areas unrelated to their competing interests. Expertise is possible without competing interests. If such a strict rule becomes impractical, minimum good practice is that people with competing interests must not be involved in decisions on products and policies in which they have a financial interest.
Read the full article here: https://www.bmj.com/content/371/bmj.m4425?utm_source=twitter&utm_medium=social&utm_term=hootsuite&utm_content=sme&utm_campaign=usage